Autori: Morris Shannon R
| Naslov | Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies (Article) |
| Autori | Weiss Jared Goldschmidt Jerome Andric Zoran G Dragnev Konstantin H Gwaltney Chad Skaltsa Konstantina Pritchett Yili Antal Joyce M Morris Shannon R Daniel Davey |
| Info | CLINICAL LUNG CANCER, (2021), vol. 22 br. 5, str. 449-460 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study (Article) |
| Autori | Hart Lowell L Ferrarotto Renata Andric Zoran G Beck Thaddeus J Subramanian Janakiraman Radosavljevic Davorin Z Zaric Bojan Hanna Wahid T Aljumaily Raid Owonikoko Taofeek K Verhoeven Didier Xiao Jie Morris Shannon R Antal Joyce M Hussein Maen A |
| Info | ADVANCES IN THERAPY, (2021), vol. 38 br. 1, str. 350-365 |
| Projekat | G1 Therapeutics, Inc. (Research Triangle Park, NC) |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
